Pure Global

A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment - Trial NCT06318676

Access comprehensive clinical trial information for NCT06318676 through Pure Global AI's free database. This Phase 1 trial is sponsored by Celgene and is currently Not yet recruiting. The study focuses on Renal Impairment. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06318676
Phase 1
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06318676
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment
A Phase 1, Multi-center, Open-label, Single-dose Study to Assess the Pharmacokinetics of Mezigdomide (BMS-986348, CC-92480) in Adult Participants With Normal Renal Function, Severe Renal Impairment, and End-stage Renal Disease

Study Focus

Renal Impairment

Mezigdomide

Interventional

drug

Sponsor & Location

Celgene

Miami Lakes,Orlando,Orlando, United States of America

Timeline & Enrollment

Phase 1

Mar 15, 2024

Mar 05, 2025

32 participants

Primary Outcome

Maximum observed concentration (Cmax),Area under the plasma concentration-time curve (AUC),Area under the plasma concentration-time curve from time 0 to time of last quantifiable concentration (AUC(0-T))

Summary

The purpose of this study is to evaluate the drug levels of mezigdomide in participants with
 renal impairment.

ICD-10 Classifications

Renal failure
Disorders resulting from impaired renal tubular function
Disorder resulting from impaired renal tubular function, unspecified
Other disorders resulting from impaired renal tubular function
Acute renal failure

Data Source

ClinicalTrials.gov

NCT06318676

Non-Device Trial